
Hillstream BioPharma, Inc. Common Stock
HILS
HILS: Hillstream BioPharma Inc is a pre-clinical biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (IMCD), and targeted immuno-oncology novel biologics, for the treatment drug resistant cancers. The company product, HSB-1216, is an IMCD inducer, targeting a variety of solid tumors.
moreShow HILS Financials
Recent trades of HILS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HILS's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on HILS's company Twitter account
Number of mentions of HILS in WallStreetBets Daily Discussion
Recent insights relating to HILS
Recent picks made for HILS stock on CNBC
ETFs with the largest estimated holdings in HILS
Flights by private jets registered to HILS